646 related articles for article (PubMed ID: 32275914)
1. Type 1 interferons as a potential treatment against COVID-19.
Sallard E; Lescure FX; Yazdanpanah Y; Mentre F; Peiffer-Smadja N
Antiviral Res; 2020 Jun; 178():104791. PubMed ID: 32275914
[TBL] [Abstract][Full Text] [Related]
2. A role for retinoids in the treatment of COVID-19?
Trasino SE
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1765-1767. PubMed ID: 32459003
[TBL] [Abstract][Full Text] [Related]
3. Interplay between SARS-CoV-2 and the type I interferon response.
Sa Ribero M; Jouvenet N; Dreux M; Nisole S
PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
[TBL] [Abstract][Full Text] [Related]
4. Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents.
Izzi A; Messina V; Rinaldi L; Maggi P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5193-5194. PubMed ID: 32495848
[No Abstract] [Full Text] [Related]
5. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: lambda interferon against viral load and hyperinflammation.
Andreakos E; Tsiodras S
EMBO Mol Med; 2020 Jun; 12(6):e12465. PubMed ID: 32333818
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
8. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
9. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
Vargas M; Servillo G; Einav S
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
[TBL] [Abstract][Full Text] [Related]
10. COVID-19: Rescue by transcriptional inhibition.
Shilatifard A
Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937442
[No Abstract] [Full Text] [Related]
11. HIV and SARS-CoV-2: points to consider to face this new pandemic.
Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
[TBL] [Abstract][Full Text] [Related]
12. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
Calligari P; Bobone S; Ricci G; Bocedi A
Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
[TBL] [Abstract][Full Text] [Related]
13. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
Park A; Iwasaki A
Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097
[TBL] [Abstract][Full Text] [Related]
14. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
Krishan K; Kanchan T
Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 therapeutic options for patients with kidney disease.
Izzedine H; Jhaveri KD; Perazella MA
Kidney Int; 2020 Jun; 97(6):1297-1298. PubMed ID: 32317113
[No Abstract] [Full Text] [Related]
16. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
17. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!
Lazzerini PE; Boutjdir M; Capecchi PL
Circulation; 2020 Jul; 142(1):7-9. PubMed ID: 32286863
[No Abstract] [Full Text] [Related]
18. Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus.
Xu P; Sun GD; Li ZZ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5797-5809. PubMed ID: 32495918
[TBL] [Abstract][Full Text] [Related]
19. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
20. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
